LeMaitre Vascular, Inc. (LMAT) Reports Q4 Earnings of $0.02; Guides Q1, FY12 Revs
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $81.86 -0.56%
Financial Fact:
Foreign currency gain (loss): -61K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Foreign currency gain (loss): -61K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
LeMaitre Vascular, Inc. (NASDAQ: LMAT) reported Q4 EPS of $0.02, versus $0.12 reported last year. Revenue for the quarter came in at $13.4 million, versus $14.43 million reported last year.
Sees Q1 2012 revenue of $13.8 million, versus the consensus of $13.4 million.
Sees FY2012 revenue of $57.5 million, versus the consensus of $59.1 million.
For earnings history and earnings-related data on LeMaitre Vascular, Inc. (LMAT) click here.
Sees Q1 2012 revenue of $13.8 million, versus the consensus of $13.4 million.
Sees FY2012 revenue of $57.5 million, versus the consensus of $59.1 million.
For earnings history and earnings-related data on LeMaitre Vascular, Inc. (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley Upgrades Sangfor Technologies Inc (300454:CH) to Overweight
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
